More
    Guided Solutions - Connecting Talent With Innovation/div>

    FemDx Medsystems announces successful first-in-human study

    FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....

    Perfuze completes enrollment in stroke catheter study

    Perfuze announced it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also shared a new...

    Fire1 heart failure system performs well in first-in-human study

    Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system. The FUTURE-HF study evaluated the safety and feasibility...

    Data backs Cala neurostim for treating essential tremor

    Cala announced new results from multiple clinical studies further expanding the body of evidence for its TAPS therapy. TAPS (transcutaneous afferent patterned stimulation) therapy...

    Anaconda Biomed enrolls first patient in study of funnel catheter for treating stroke

    Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel Catheter. Dr. Shahram Majidi performed...

    Study backs Median Technologies’ AI lung cancer screening software

    Median Technologies, manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a...

    New study demonstrates benefit of Neo Medical’s spine surgery tech

    A new study has demonstrated the value of Neo Medical’s Force Control technology and pedicle screws in thoracolumbar fusion spine surgery. Published in the April...

    JenaValve data backs TAVR system for treating aortic regurgitation

    JenaValve announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system. The ALIGN-AR pivotal trial evaluated Trilogy in high-risk...

    AtaCor Medical enrolls first patient in ASCEND-EV trial

    AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead system. The San Clemente, California–based company enrolled its first patient...

    Latest articles